Data\Bio\SEC\8kmay02
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

                          Date of Report: - May 2, 2001

                                BIORELEASE CORP.
                                 ---------------
               (Exact name of registrant as specified in charter)


  Delaware                     0-15260                   88-0218411
  --------                     -------                   ----------
Jurisdiction of            Commission File              I. R. S. Employer
Incorporation              Number                       Identification
                                                        Number

               340 Granite Street, Suite 200, Manchester, NH 03102
               ---------------------------------------------------
                    (Address of principal executive offices)

                         Registrant's telephone number:
                                 (603) 641-8443

Item 5.  Other Events

On May 2nd, 2001,  holders of a majority of the Company's common stock consented
in writing to five corporate actions in lieu of a meeting of the shareholders of
the Company.  The effect of these five consents is to (1) amend the  Certificate
of  Incorporation  to change the name of the Corporation to BRL Holdings,  Inc.;
(2) amend the  Articles  of  Incorporation  to  authorize a new class of shares,
namely 5,000,000 shares of $0.10 per share value Preferred Stock; (3) to reverse
split the  outstanding  shares on a one for 12.5 basis,  so that the  17,924,238
pre-reverse common shares currently outstanding will become a total of 1,433,939
shares (all  fractional  shares to be rounded to the nearest whole  share);  (4)
that,  subject to the effectiveness of a registration  statement on Form SB-2 or
other  applicable  Form, the Corporation  will distribute  prorata to its common
shareholders,  one  share  of the  common  stock  of its  subsidiary  Biorelease
Technologies,  Inc. ("BTI") for each 25 pre-reverse  split common shares held on
the record date  (total of 800,000  shares to be  distributed);  and finally (5)
that the  officers  and  directors  are  authorized  to  submit  an  Information
Statement pursuant to Schedule 14C under the Securities  Exchange Act of 1934 to
all Company  shareholders which did not sign the referenced Consent.  The record
date to be eligible for the reverse  split and the BTI stock  dividend is set as
May 31st, 2001.







                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
                                 BIORELEASE CORP

                                                 /s/ R. Bruce Reeves, President

Dated:        May 2, 2001